FIELD: medicine.
SUBSTANCE: invention relates to an antialcoholic means containing a peptide with molecular weight of 6734 Da, created by genetic engineering (plasmid) technology.
EFFECT: reduction of alcoholic motivation and reinforcing properties of ethanol due to blockade of specific orexin A receptors in the brain.
3 ex, 2 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR REDUCTION OF MORBID ATTRACTION TO ETHANOL IN POSTABSTINENT PERIOD | 2007 |
|
RU2373927C2 |
| AGENT FOR MANAGING ALCOHOL ABSTINENCE SYNDROME | 2012 |
|
RU2521226C2 |
| LOW MOLECULAR WEIGHT MIMETIC OF BRAIN NEUROTROPHIC FACTOR WITH ANALGESIC, ANXIOLYTIC AND ANTIADDICTIVE EFFECTS | 2020 |
|
RU2759023C2 |
| ANTIALCOHOLIC AGENT | 1989 |
|
RU2011382C1 |
| PHARMACEUTICAL COMBINATION FOR TREATMENT OF ALCOHOLIC DEPENDENCE | 2017 |
|
RU2681931C2 |
| MEANS FOR REDUCING ALCOHOL MOTIVATION IN ALCOHOL DEPENDENCE | 2014 |
|
RU2582966C2 |
| 17ALPHA,21-DIHYDROXYPREGN-4-ENE-3,20-DIONE 17ALPHA,21-DIACETATE SHOWING ANTIALCOHOLIC AND ADAPTOGENIC ACTIVITY | 1999 |
|
RU2172173C2 |
| ANXIOLYTIC AND CEREBROPROTECTIVE AGENT REDUCING INCLINATION TO ALCOHOL | 2008 |
|
RU2393855C1 |
| REMEDY AGAINST PATHOLOGIC INCLINATION FOR ALCOHOLISM | 0 |
|
SU1828751A1 |
| METHOD FOR CORRECTING NEUROLOGICAL DISTURBANCES ACCOMPANYING ALCOHOL INTOXICATION | 2014 |
|
RU2561063C1 |
